July 26, 2013
AnGes MG announced on July 23 that a PI clinical study of its atopic dermatitis treatment using NF-κB decoy oligo, which is currently underway in Japan, has confirmed its safety for skin. The compound is being codeveloped by Shionogi. The...read more